Skip to main content

Published locations for In phase III trial, bevacizumab prolongs progression-free survival for ovarian cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. In phase III trial, bevacizumab prolongs progression-free survival for ovarian cancer

User login

  • Reset your password
  • /content/phase-iii-trial-bevacizumab-prolongs-progression-free-survival-ovarian-cancer
  • /obgynnews/article/78841/gynecologic-cancer/phase-iii-trial-bevacizumab-prolongs-progression-free
  • /acssurgerynews/article/78841/gynecologic-cancer/phase-iii-trial-bevacizumab-prolongs-progression
  • /oncologypractice/article/78841/gynecologic-cancer/phase-iii-trial-bevacizumab-prolongs-progression
  • /obgyn/article/78841/gynecologic-cancer/phase-iii-trial-bevacizumab-prolongs-progression-free
  • /hematology-oncology/article/78841/gynecologic-cancer/phase-iii-trial-bevacizumab-prolongs
  • /surgery/article/78841/gynecologic-cancer/phase-iii-trial-bevacizumab-prolongs-progression-free